Premium Only Content
This video is only available to Rumble Premium subscribers. Subscribe to
enjoy exclusive content and ad-free viewing.
We believe the risk-benefit profile for our Alzheimer’s drug is acceptable, says Eisai U.S. CEO
2 years ago
2
Ivan Cheung, Eisai U.S. CEO, joins ‘Closing Bell’ to discuss the results of Eisai’s experimental Alzheimer’s phase three trial, the side effects associated with the Alzheimer’s drug and more.
Loading comments...
-
LIVE
Right Side Broadcasting Network
21 hours agoLIVE: RSBN Post-Inauguration Coverage - 1/22/25
5,283 watching -
LIVE
LFA TV
15 hours ago$3 TRILLION IN 3 DAYS! | LIVE FROM AMERICA 1.22.25 11am
3,068 watching -
LIVE
Caleb Hammer
47 minutes agoMail-Order Bride Hates Her New Husband | Financial Audit
152 watching -
LIVE
MYLUNCHBREAK CHANNEL PAGE
17 hours agoThe Old World Marathon #1
247 watching -
1:15:47
Graham Allen
3 hours agoNBC ATTACKS Pete Hegseth Just Before his Confirmation!! + Woke Bishop LECTURES Trump!
57.2K49 -
LIVE
Rethinking the Dollar
33 minutes agoWednesday Morning Check-In: Trump's Technocratic Team Takeover In Full Effect
117 watching -
LIVE
Matt Kohrs
11 hours ago🔴[LIVE] TRUMP PUMPS MARKETS HIGHER 🚀🚀🚀 || The MK Show
1,062 watching -
2:44:21
The Gundie Awards
13 hours ago $0.24 earnedThe 6th Annual Gundie Awards
3.2K -
57:00
PMG
10 hours ago $0.01 earned"Hannah Faulkner and Grace Reilly | 10 MILLION Gun Owners AREN'T Registered To Vote?!"
3.39K -
32:09
BonginoReport
5 hours agoBeauty is Back (Ep.123) - 01/22/2025
55.7K107